In IL-13Rα2-positive pancreatic cancer, the possibility of celiac plexus invasion can be predicted in advance of surgery, and it may be possible to manage the pain in the patients receiving chemotherapy. This evidence concerns the gene IL13RA2 and pancreatic neoplasm.